Artiva Biotherapeutics downgraded by Needham
Stocks in this Quantisnow insightHealth Care
Historical context for ARTV
Across the 25 sessions after earlier ARTV headlines, the stock closed higher 10 times and lower 15 times, with a median move of 4.6% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | ARTV | SPY |
|---|---|---|---|
| Oct 27, 2026 | Artiva Biotherapeutics downgraded by Wedbush with a new price targetand 1 other headline that session | -30.7% | +0.6% |
| Oct 2, 2026 | Artiva Biotherapeutics Announces Multiple AlloNK® Data Presentations at the American College of Rheumatology (ACR) Convergence 2026 | +0.6% | +0.7% |
| Oct 1, 2026 | Artiva Biotherapeutics Highlights Updated AlloNK® Data in Sjögren Disease Presented at the 17th International Symposium on Sjögren’s Disease (ISSjD 2026) | -4.6% | +0.2% |
| Sep 23, 2026 | Artiva Biotherapeutics Announces Oral Presentation of AlloNK® Clinical Data at the 17th International Symposium on Sjögren’s Disease | -4.6% | -0.7% |
| Sep 17, 2026 | Artiva Biotherapeutics to Participate in the Stifel 2026 Virtual Immunology and Inflammation Forum | -1.9% | +1.1% |
| Sep 8, 2026 | Artiva Biotherapeutics Provides Update on Planned AlloNK® Data Disclosures and Development Milestones for the Remainder of 2026 | -2.8% | -0.5% |
Keep researching ARTV
- What is Analyst downgrade?A sell-side analyst's move to a less favorable rating on a stock, such as from Buy to Hold, usually published with a lower price target and rationale.
- Analyst upgrades and downgradesAn analyst upgrade or downgrade is a change in a sell-side analyst's stock rating. Learn what Buy, Hold and Sell mean, how price targets work and which changes matter.
- ARTV insider tradesEvery buy and sale reported by Artiva Biotherapeutics Inc. officers, directors and large holders.
- ARTV financial statementsRevenue, profit, cash flow and balance sheet from Artiva Biotherapeutics Inc.'s SEC filings.
Quantisnow market dataNASDAQ
ARTV
Artiva Biotherapeutics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Listed since
- 2024
Get push alerts for ARTV
Full ARTV profile on Quantisnow Follow ARTV and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time